因不断出现关于服用喹诺酮类抗菌药加替沙星(gatifloxacin,商品名为天坤,Tequin)后发生严重低血糖和高血糖病例的报告,百时美施贵宝公司(BristolMyersSquibb)已在美国对其标签进行了修改,在“警告”栏中强调了这一不良反应,将糖尿病列为该药的禁忌证,并确定了除糖尿病外的其它 Due to reports of serious hypoglycaemic and hyperglycemic episodes following the administration of a quinolone antibiotic, gatifloxacin (Tequin), Bristol Myers Squibb has been labeled in the United States Was amended to highlight this adverse reaction in the “Warning” column, with diabetes as a contraindication for the drug and to identify other than diabetes